A detailed history of Franklin Resources Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Franklin Resources Inc holds 258,396 shares of LEGN stock, worth $10.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
258,396
Holding current value
$10.4 Million
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$43.55 - $59.88 $11.3 Million - $15.5 Million
258,396 New
258,396 $12.6 Million
Q1 2024

May 13, 2024

SELL
$55.06 - $69.99 $1.02 Million - $1.3 Million
-18,508 Reduced 4.81%
366,388 $20.6 Million
Q4 2023

Feb 09, 2024

BUY
$57.25 - $69.74 $458 - $557
8 Added 0.0%
384,896 $23.2 Million
Q3 2023

Nov 13, 2023

SELL
$63.16 - $76.5 $2.62 Million - $3.17 Million
-41,420 Reduced 9.72%
384,888 $25.9 Million
Q2 2023

Aug 11, 2023

BUY
$46.28 - $75.01 $89,598 - $145,219
1,936 Added 0.46%
426,308 $29.4 Million
Q1 2023

May 12, 2023

SELL
$43.42 - $57.37 $1.06 Million - $1.4 Million
-24,464 Reduced 5.45%
424,372 $20.5 Million
Q4 2022

Feb 10, 2023

BUY
$38.8 - $55.46 $7,953 - $11,369
205 Added 0.05%
448,836 $22.4 Million
Q2 2022

Aug 11, 2022

BUY
$33.54 - $55.0 $13,919 - $22,825
415 Added 0.09%
448,631 $24.7 Million
Q3 2021

Nov 12, 2021

SELL
$35.31 - $50.56 $1.72 Million - $2.46 Million
-48,695 Reduced 9.8%
448,216 $22.7 Million
Q1 2021

May 13, 2021

SELL
$23.55 - $32.4 $8.13 Million - $11.2 Million
-345,086 Reduced 40.98%
496,911 $14.4 Million
Q4 2020

Feb 10, 2021

SELL
$25.8 - $32.39 $4.8 Million - $6.03 Million
-186,119 Reduced 18.1%
841,997 $23.7 Million
Q3 2020

Nov 12, 2020

BUY
$27.5 - $39.61 $14.8 Million - $21.3 Million
537,860 Added 109.71%
1,028,116 $31.7 Million
Q2 2020

Aug 13, 2020

BUY
$36.1 - $42.56 $17.7 Million - $20.9 Million
490,256 New
490,256 $17.7 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.